Celdaz 200mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Dacarbazine (200mg)
Overview Celdaz 200mg Injection
Lymphoma and malignant melanoma (a skin cancer) are treated with Celdaz 200mg Injection. Other uses may be determined by your physician. Administered intravenously by a healthcare provider, ideally at the same time daily, the dosage and frequency are tailored by your doctor to your specific condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdosing can lead to severe adverse reactions. Therapeutic benefits might not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include nausea, vomiting, leukopenia, and injection site discomfort. Report persistent or worsening symptoms to your doctor; management strategies may be available. Serious side effects are possible with this potent medication, which can compromise immune function and potentially affect blood, liver, or kidney health. Report unusual bleeding or bruising, fatigue, anorexia, or jaundice immediately. Regular blood monitoring will be recommended. Inform your doctor of any pre-existing liver or kidney conditions, or concurrent use of anti-infectives, before starting treatment. Interactions with other medications are possible; disclose all current medications. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception is crucial for both partners throughout the treatment period.
Primary Ingredients of Celdaz 200mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Celdaz 200mg Injection
Aggressive skin cancer|Hodgkin lymphoma
Major Benefits of Celdaz 200mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Celdaz 200mg Injection:
- Nausea
- Vomiting
- Injection site pain
- Decreased white blood cell count
- Loss of appetite
How to use Celdaz 200mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Celdaz 200mg Injection works:
Oncocel 200mg Injection is a cancer treatment that functions by disrupting the genetic structure (DNA and RNA) within cancerous cells, thereby inhibiting their proliferation and expansion.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Celdaz 200mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Celdaz 200mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Administration of Celdaz 200mg Injection while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Celdaz 200mg Injection may result in adverse reactions impacting driving capabilities. This effect stems from potential central nervous system side effects associated with the injection.
KidneyCAUTION
Exercise caution when administering Celdaz 200mg Injection to individuals with impaired renal function. Dosage modification of Celdaz 200mg Injection may be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, administration of Celdaz 200mg Injection requires careful consideration. Dosage modification of Celdaz 200mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Celdaz 200mg Injection :
Should you forget a Celdaz 200mg Injection, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Celdaz 200mg Injection
| Label | Value |
|---|---|
| Chemical Category | Triazene compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Alkylating compound |
3,018 People bought this recently